Search
for
Sort by
Research 331–360 of 1000+
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- 6 Current concepts of polycystic ovary syndrome
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
- The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review
- Teneligliptin-induced hair loss: A case report
- Global hotspots and trends in Acanthosis nigricans research: A bibliometric and visualized analysis
- Obesity and Wound Healing: Focus on Mesenchymal Stem Cells
- Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Association of Polish Surgeons, and the College of Family Physicians in Poland
- Clinicopathological factors associated with trichilemmal cysts
- Factors Associated with Acute Telogen Effluvium and COVID-19 Infection
- A 36-Year-Old Woman With an Unexpected Cause of Hypokalemia
- Molecular Aspects of Polycystic Ovarian Syndrome in Female Population in Karnataka at the Southwestern Region of India
- Clinical Evaluation and Therapeutic Outcome in Hirsutism
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Type 2 Diabetic Mellitus Inhibits Skin Renewal through Inhibiting WNT-Dependent Lgr5+ Hair Follicle Stem Cell Activation in C57BL/6 Mice
- Endocrine abnormalities in ring chromosome 11: a case report and review of the literature
- Polycystic ovary syndrome
- Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
- Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome
- Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
- Complex X chromosome rearrangement associated with multiorgan autoimmunity
- Interval training and cardiometabolic health in reproductive-aged females
- AN OVERVIEW ON POLYCYSTIC OVARIAN SYNDROME
- 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
- Update on polycystic ovary syndrome
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic